These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

492 related items for PubMed ID: 19075138

  • 1. Hematologic safety of dapsone gel, 5%, for topical treatment of acne vulgaris.
    Piette WW, Taylor S, Pariser D, Jarratt M, Sheth P, Wilson D.
    Arch Dermatol; 2008 Dec; 144(12):1564-70. PubMed ID: 19075138
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Clinical evidence for the role of a topical anti-inflammatory agent in comedonal acne: findings from a randomized study of dapsone gel 5% in combination with tazarotene cream 0.1% in patients with acne vulgaris.
    Tanghetti E, Dhawan S, Green L, Ling M, Downie J, Germain MA, Kasteler JS, Kircik L, Oefelein MG, Draelos Z.
    J Drugs Dermatol; 2011 Jul; 10(7):783-92. PubMed ID: 21720661
    [Abstract] [Full Text] [Related]

  • 8. Effects of tazarotene 0.1 % cream in the treatment of facial acne vulgaris: pooled results from two multicenter, double-blind, randomized, vehicle-controlled, parallel-group trials.
    Shalita AR, Berson DS, Thiboutot DM, Leyden JJ, Parizadeh D, Sefton J, Walker PS, Gibson JR, Tazarotene Cream in Acne Clinical Study Investigator Group.
    Clin Ther; 2004 Nov; 26(11):1865-73. PubMed ID: 15639698
    [Abstract] [Full Text] [Related]

  • 9. Efficacy and Safety of Once-Daily Dapsone Gel, 7.5% for Treatment of Adolescents and Adults With Acne Vulgaris: Second of Two Identically Designed, Large, Multicenter, Randomized, Vehicle-Controlled Trials.
    Eichenfield LF, Lain T, Frankel EH, Jones TM, Chang-Lin JE, Berk DR, Ruan S, Kaoukhov A.
    J Drugs Dermatol; 2016 Aug 01; 15(8):962-9. PubMed ID: 27537997
    [Abstract] [Full Text] [Related]

  • 10. Tretinoin gel microspheres 0.04% versus 0.1% in adolescents and adults with mild to moderate acne vulgaris: a 12-week, multicenter, randomized, double-blind, parallel-group, phase IV trial.
    Berger R, Rizer R, Barba A, Wilson D, Stewart D, Grossman R, Nighland M, Weiss J.
    Clin Ther; 2007 Jun 01; 29(6):1086-97. PubMed ID: 17692723
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Treatment Response With Once-Daily Topical Dapsone Gel, 7.5% for Acne Vulgaris: Subgroup Analysis of Pooled Data from Two Randomized, Double-Blind Stu.
    Draelos ZD, Rodriguez DA, Kempers SE, Bruce S, Peredo MI, Downie J, Chang-Lin JE, Berk DR, Ruan S, Kaoukhov A.
    J Drugs Dermatol; 2017 Jun 01; 16(6):591-598. PubMed ID: 28686777
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Efficacy, Safety, and Tolerability of Topical Dapsone Gel, 7.5% for Treatment of Acne Vulgaris by Fitzpatrick Skin Phototype.
    Taylor SC, Cook-Bolden FE, McMichael A, Downie JB, Rodriguez DA, Alexis AF, Callender VD, Alvandi N.
    J Drugs Dermatol; 2018 Feb 01; 17(2):160-167. PubMed ID: 29462223
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.